Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06976996

Efficacy of Esketamine Combined With Different General Anesthetics on Quality of Postoperative Recovery

Efficacy of Subanesthetic Dose of Esketamine Combined With Different General Anesthetics on Quality of Early Postoperative Recovery in Patients Undergoing Painless Gastrointestinal Endoscopy

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
190 (estimated)
Sponsor
Northern Jiangsu People's Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To explore the effect of subanesthetic-dose esketamine combined with different general anesthetic drugs on the quality of postoperative recovery in patients undergoing painless gastrointestinal endoscopy.

Detailed description

In this study, we planned to conduct a single-center, prospective, randomized, controlled, double-blind clinical trial to explore the effect of subanesthetic dose esketamine combined with different general anesthesia drugs on the postoperative recovery quality of patients undergoing painless gastrointestinal endoscopy combined with several commonly used intravenous general anesthesia drugs, aiming at gastroscopy combined with colonoscopy, a representative type of diagnosis and treatment of painless and comfortable anesthesia, and to provide more evidence-based medical evidence for clinical work.

Conditions

Interventions

TypeNameDescription
DRUGnormal salinenormal saline (0.15 ml/kg)
DRUGesketamineesketamine (0.15 mg/kg)
DRUGpropofolpropofol (2 mg/kg)
DRUGetomidate-ciprofol (EC) mixtureetomidate-ciprofol (EC) mixture (0.2 ml/kg)
DRUGciprofolciprofol (0.5 mg/kg)
DRUGetomidate-propofol (EP) mixtureetomidate-propofol (EP) mixture (0.2 ml/kg)

Timeline

Start date
2025-03-16
Primary completion
2025-12-15
Completion
2025-12-15
First posted
2025-05-16
Last updated
2025-05-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06976996. Inclusion in this directory is not an endorsement.